Medicinal attributes of pyrazolo [3, 4-d] pyrimidines: a review

M Chauhan, R Kumar - Bioorganic & medicinal chemistry, 2013 - Elsevier
Pyrazolopyrimidines are the fused heterocyclic ring systems which structurally resemble
purines which prompted biological investigations to assess their potential therapeutic …

Biologically Driven Synthesis of Pyrazolo[3,4-d]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical …

S Schenone, M Radi, F Musumeci, C Brullo… - Chemical …, 2014 - ACS Publications
1. INTRODUCTION Nitrogen-containing heterocycles are widely distributed in nature and
essential for life, playing a vital role in the metabolism of all living cells. Among the many …

Recent developments in anticancer kinase inhibitors based on the pyrazolo [3, 4-d] pyrimidine scaffold

DJ Baillache, A Unciti-Broceta - RSC medicinal chemistry, 2020 - pubs.rsc.org
Pyrazolo [3, 4-d] pyrimidines have become of significant interest for the medicinal chemistry
community as a privileged scaffold for the development of kinase inhibitors to treat a range …

Chalcones as Versatile Synthons for the Synthesis of 5-and 6-membered Nitrogen Heterocycles

H MT Albuquerque, C MM Santos… - Current Organic …, 2014 - ingentaconnect.com
Chalcones belong to the flavonoid family which constitutes one of the major classes of
naturally occurring oxygen heterocyclic compounds. The α, β-unsaturated carbonyl system …

LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators

F Manetti - Medicinal research reviews, 2012 - Wiley Online Library
The LIM kinases 1 and 2 (LIMK1 and LIMK2) are dual specificity (serine/threonine and
tyrosine) kinases. Although they show significant structural similarity, LIMK1 and LIMK2 …

Synthesis, anticancer evaluation, and molecular docking studies of some novel 4, 6-disubstituted pyrazolo [3, 4-d] pyrimidines as cyclin-dependent kinase 2 (CDK2) …

S Cherukupalli, B Chandrasekaran, V Kryštof… - Bioorganic …, 2018 - Elsevier
Abstract A novel series of 4, 6-disubstituted pyrazolo [3, 4-d] pyrimidines (7–43) bearing
various anilines at C-4 position and thiophenethyl or thiopentane moieties at C-6 position …

Synthesis of pyrazole derivatives possessing anticancer activity: Current status

S Kumari, S Paliwal, R Chauhan - synthetic communications, 2014 - Taylor & Francis
Pyrazole is a versatile lead compound to design potent bioactive molecules for drug
discovery and development, particularly in cancer therapy. The aim of this review is to …

Synthesis of some pyrazolines and pyrimidines derived from polymethoxy chalcones as anticancer and antimicrobial agents

SAF Rostom, MH Badr, HA Abd El Razik… - Archiv der …, 2011 - Wiley Online Library
The synthesis of a series of certain polymethoxy chalcones and some derived pyrazole,
pyrimidine, and thiazolopyrimidine ring structures is reported. Eleven compounds 4, 6, 9, 11 …

Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems …

SAF Rostom - Bioorganic & Medicinal Chemistry, 2010 - Elsevier
The synthesis of two novel series of 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazoles linked to
either polysubstituted 1H-pyrazole counterparts through a carbonyl bridge, or to some …

Design, Synthesis, Biological Activity, and ADME Properties of Pyrazolo[3,4-d]pyrimidines Active in Hypoxic Human Leukemia Cells: A Lead Optimization Study

M Radi, E Dreassi, C Brullo, E Crespan… - Journal of medicinal …, 2011 - ACS Publications
A family of dual Src/Abl inhibitors characterized by a substituted pyrazolo [3, 4-d] pyrimidine
scaffold was previously reported by us and proved to be active against several tumor cell …